New study probes brain inflammation to unlock dementia mysteries

NCT ID NCT06870838

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This observational study looks at how brain inflammation contributes to frontotemporal lobar degeneration (FTLD), a group of disorders that cause dementia. Researchers will use advanced brain scans, blood tests, and spinal fluid analysis in 110 participants to find biomarkers that could help distinguish between different types of FTLD and track disease progression. The study does not test any treatment, but aims to improve understanding and future diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand and diagnose different types of frontotemporal dementia earlier.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve symptoms, and results may take years to influence patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA (BVFTD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Erasmus MC

    Rotterdam, 3015GE, Netherlands

  • Leiden University Medical Center

    Leiden, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.